Adolphs H D, Schwabe H W, Helpap B, Volz C
Urol Res. 1984;12(2):129-33. doi: 10.1007/BF00257179.
During and after chemoimmune prophylaxis with i.v. cyclophosphamide (CTX) and both intravesical and systemic BCG-treatment, the bladder mucosa is prone to morphological changes which might resemble tumor recurrences. Therefore, morphological parameters which can discriminate between treatment effects and tumor recurrences are of interest. In a prospective study, routine cytology, determination of granulocytes, lymphocytes, and macrophages in the urine sediment as well as flow-cytophotometry (FCM) for DNA analysis were performed before, during, and after chemoimmune prophylaxis. In addition, bladder biopsies and all recurrent tumors were histologically analysed. Our results show that FCM is the best method for monitoring the bladder mucosa for recurrent tumors during treatment. After termination of BCG, it takes at least 4 months for cytological normalization to take place. Urine excretion of granulocytes, lymphocytes, and macrophages does not correlate with this process. Histological alterations during treatment are demonstrated; their normalization requires at least 3 months. In 10% of the patients chronic inflammatory lesions ("pseudotumors") develop.
在静脉注射环磷酰胺(CTX)以及膀胱内和全身卡介苗治疗的化疗免疫预防期间及之后,膀胱黏膜容易出现形态学改变,这些改变可能类似于肿瘤复发。因此,能够区分治疗效果和肿瘤复发的形态学参数备受关注。在一项前瞻性研究中,在化疗免疫预防之前、期间和之后进行了常规细胞学检查、尿沉渣中粒细胞、淋巴细胞和巨噬细胞的测定以及用于DNA分析的流式细胞光度法(FCM)。此外,对膀胱活检组织和所有复发性肿瘤进行了组织学分析。我们的结果表明,FCM是治疗期间监测膀胱黏膜是否复发肿瘤的最佳方法。卡介苗治疗结束后,细胞学至少需要4个月才能恢复正常。粒细胞、淋巴细胞和巨噬细胞的尿排泄量与这一过程无关。治疗期间出现了组织学改变;其恢复正常至少需要3个月。10%的患者会出现慢性炎性病变(“假肿瘤”)。